November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Shushan Hovsepyan: How do you approach angiosarcoma cases?
Nov 16, 2024, 10:18

Shushan Hovsepyan: How do you approach angiosarcoma cases?

Shushan Hovsepyan, the Editor in Chief of the OncoDaily Medical Journal, posted on LinkedIn about recent paper by Elena Palassini et al., titled “Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group” published on Cancer Treatment Reviews.

Authors: Elena Palassini, Giacomo Giulio Baldi, Sara Sulfaro, Marta Barisella, Giuseppe Bianchi, Domenico Campanacci, Marco Fiore, Marco Gambarotti, Massimiliano Gennaro, Carlo Morosi, Federico Navarria, Emanuela Palmerini, Claudia Sangalli, Marta Sbaragliani, Annalisa Trama, Sebastian Asaftei, Giuseppe Badalamenti, Rossella Bertulli, Alexia Francesca Bertuzzi, Roberto Biagini, Angela Buonadonna, Antonella Brunello, Dario Callegaro, Ferdinando Cananzi, Marco Cianchetti, Paola Collini, Danila Comandini, Annalisa Curcio, Lorenzo D’Ambrosio, Tommaso De Pas, Angelo Paolo Dei Tos, Virginia Ferraresi, Andrea Ferrari, Alessandro Franchi, Anna Maria Frezza, Elena Fumagalli, Matteo Ghillini, Daniela Greto, Giovanni Grignani, Michele Guida, Toni Ibrahim, Marco Krenglik, Roberto Luksche, Andrea Marrari, Marinella Mastore, Alessandra Merlin, Giuseppe Maria Milano, Piera Navarri, Maria Abbondanza Pantaleo, Antonina Parafiori, Ilaria Pellegrini, Elisabetta Pennacchioli, Marco Rastrelli, Elisabetta Setola, Salvatore Tafuto, Salvatore Turano, Sergio Valeri, Bruno Vincenzi, Viviana Vitolo, Andrei Ivanescu, Fiammetta Paloschi, Paolo Giovanni Casali, Alessandro Gronchi, Silvia Stacchiotti

Shushan Hovsepyan: How do you approach angiosarcoma cases?

“Friday evening read…

How do you approach angiosarcoma cases? Let’s discuss and learn together.

Picture this: you’re in a tumor board meeting, discussing a rare and aggressive case of angiosarcoma. The patient is sitting outside, waiting for answers. But angiosarcoma doesn’t fit neatly into any standard guidelines. It’s aggressive, unpredictable, and rare. What do you do?

Fortunately, a new consensus paper by the Italian Sarcoma Group offers much-needed guidance for localized disease.”

Shushan Hovsepyan is the Editor in Chief of the OncoDaily Medical Journal, a pediatric oncologist and an adjunct assistant professor at the Yerevan State Medical University. Currently, she is the Editor-in-Chief of OncoDaily Medical Journal.

She completed her clinical fellowship at the National Institute of Cancer in Milan, Italy and at the St. Anna Children’s Research Hospital in Austria Furthermore, she held a research fellowship position at the European Organisation for Research and Treatment of Cancer in Brussels, Belgium. She is a former co-chair of the SIOP Global Health Network Education and Training Working Group.